Atlas Trials

Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure

Clinical trial NCT06578520 · RECRUITING

Trial details

NCT number
NCT06578520
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure
Start date
2024-07-30
Primary completion
2025-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.